These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2598177)

  • 41. Effector phenotypes and mechanisms of antitumor immune reactivity of tumor-immunized and tumor-bearing mice in two syngeneic tumors.
    Fuyama S; Komatsu H; Arai S
    Cell Immunol; 1991 Oct; 137(1):200-15. PubMed ID: 1679379
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigation of the immunosuppressive activity of Physalin H on T lymphocytes.
    Yu Y; Sun L; Ma L; Li J; Hu L; Liu J
    Int Immunopharmacol; 2010 Mar; 10(3):290-7. PubMed ID: 19951747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Suppression of human interferon-gamma production by a 17 amino acid peptide homologous to the transmembrane envelope protein of retroviruses: evidence for a primary role played by monocytes.
    Haraguchi S; Liu WT; Cianciolo GJ; Good RA; Day NK
    Cell Immunol; 1992 May; 141(2):388-97. PubMed ID: 1576656
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Validation of the Candida albicans delayed-type hypersensitivity (DTH) model in the female B₆C₃F₁ mouse for use in immunotoxicological investigations.
    White KL; McLoughlin CE; Auttachoat W; Smith MJ
    J Immunotoxicol; 2012; 9(2):141-7. PubMed ID: 22339419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Successful tumour immunotherapy: possible role of antibodies to anti-inflammatory factors produced by neoplasms.
    Nelson M; Nelson DS; Spradbrow PB; Kuchroo VK; Jennings PA; Cianciolo GJ; Snyderman R
    Clin Exp Immunol; 1985 Jul; 61(1):109-17. PubMed ID: 4042416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A targeted mutation within the feline leukemia virus (FeLV) envelope protein immunosuppressive domain to improve a canarypox virus-vectored FeLV vaccine.
    Schlecht-Louf G; Mangeney M; El-Garch H; Lacombe V; Poulet H; Heidmann T
    J Virol; 2014 Jan; 88(2):992-1001. PubMed ID: 24198407
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and biological studies on analogs of cyclolinopeptide A with a shortened peptide chain.
    Siemion IZ; Pedyczak A; Strug I; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1994; 42(5-6):459-65. PubMed ID: 8572907
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evanescent delayed-type hypersensitivity: mediation by effector cells with a short life span.
    Askenase PW; Hayden B; Gershon RK
    J Immunol; 1977 Nov; 119(5):1830-5. PubMed ID: 303252
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunization against endogenous retroviral tumor-associated antigens.
    Kershaw MH; Hsu C; Mondesire W; Parker LL; Wang G; Overwijk WW; Lapointe R; Yang JC; Wang RF; Restifo NP; Hwu P
    Cancer Res; 2001 Nov; 61(21):7920-4. PubMed ID: 11691813
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An early component of delayed-type hypersensitivity mediated by T cells and mast cells.
    van Loveren H; Meade R; Askenase PW
    J Exp Med; 1983 May; 157(5):1604-17. PubMed ID: 6602201
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lack of correlation between delayed-type hypersensitivity and host resistance to Plasmodium chabaudi infection.
    McDonald V; Sherman IW
    Clin Exp Immunol; 1980 Dec; 42(3):421-7. PubMed ID: 7011608
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BCG immunopotentiation of an antitumor response: evidence for a cell-mediated mechanism.
    Hawrylko E
    J Natl Cancer Inst; 1975 Aug; 55(2):413-23. PubMed ID: 808641
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-inflammatory effect of a retrovirus-derived immunosuppressive peptide in mouse models.
    Tolstrup M; Johansen C; Toft L; Pedersen FS; Funding A; Bahrami S; Iversen L; Østergaard L; Duch M
    BMC Immunol; 2013 Nov; 14():51. PubMed ID: 24245569
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo antitumor activity of various forms of delayed-type hypersensitivity in mice.
    Lagrange PH; Thickstun PM
    J Natl Cancer Inst; 1979 Feb; 62(2):429-36. PubMed ID: 283275
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect of rubomycin and carminomycin on the delayed hypersensitivity reaction in mice immunized with ram erythrocytes].
    Vatin AE
    Antibiotiki; 1981 Oct; 26(10):750-3. PubMed ID: 6975599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones.
    Cher DJ; Mosmann TR
    J Immunol; 1987 Jun; 138(11):3688-94. PubMed ID: 2953788
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of mizoribine on effector T cell-mediated immune responses in mice.
    Kamada H; Inoue N; Takaoka Y; Nakagami K; Mori H; Nagai H
    Biol Pharm Bull; 1996 Sep; 19(9):1136-40. PubMed ID: 8889030
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suppressive and augmentative effects of recombinant human interleukin-2 upon delayed type of hypersensitivity in the mouse.
    Harada M; Mori K; Nishimoto H
    Inflammation; 1986 Jun; 10(2):167-74. PubMed ID: 3486827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of delayed-type hypersensitivity by heparin depleted of anticoagulant activity.
    Sy MS; Schneeberger E; McCluskey R; Greene MI; Rosenberg RD; Benacerraf B
    Cell Immunol; 1983 Nov; 82(1):23-32. PubMed ID: 6640675
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of cyclosporin on murine autoreactive delayed type hypersensitivity induced with syngeneic lymphoblasts.
    Langer A; Rosenmann E; Naor D
    Immunopharmacology; 1985 Dec; 10(3):147-55. PubMed ID: 3833853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.